Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ExoTech Bio is a biotechnology company specializing in the isolation and molecular profiling of exosomes for early disease detection and therapeutic applications. The company utilizes a proprietary platform to capture high-purity exosomes from various biofluids, enabling the identification of specific biomarkers for cancers such as lung and ovarian cancer. By leveraging exosome-derived cargo, ExoTech Bio aims to provide non-invasive liquid biopsy solutions that improve patient outcomes through earlier diagnosis and personalized treatment monitoring. The platform's high sensitivity allows for the detection of minimal disease signatures that are often missed by traditional diagnostic methods. Additionally, the company is exploring the potential of exosomes as targeted delivery vehicles for therapeutic payloads in oncology and other therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ExoTech Bio Solutions.